Joseph Wolk

4 results

 J&J reported $164m in coronavirus vaccine sales for the second quarter. File photograph: Nic Bothma/EPA

Pharma group Johnson & Johnson on Wednesday forecast $2.5 billion (€2.1 billion) in sales of its one-shot Covid-19 vaccine this year based on the (...)

A one-shot vaccine developed by Johnson & Johnson generated strong protection against Covid-19 in a large, late-stage trial. Photograph: Tino Romano/EPA

A one-shot vaccine developed by Johnson & Johnson generated strong protection against Covid-19 in a large, late-stage trial, raising hopes that it(...)

Johnson & Johnson expects to report data on its Covid-19 vaccine early next week and said it would be able to meet the delivery target for doses to countries with which it had signed supply agreements.

Johnson & Johnson on Tuesday said it expected to report eagerly-awaited data on its Covid-19 vaccine early next week, and that it would be able to(...)

Johnson & Johnson reported slightly better-than-expected quarterly profit on Tuesday, helped by demand for its cancer drugs. Photograph: Mike Blake/Reuters

Johnson & Johnson reported slightly better-than-expected quarterly profit on Tuesday and pushed its full-year forecast higher, as demand for its c(...)